These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15200949)

  • 1. Targeted proteomic study of the cyclin-Cdk module.
    Archambault V; Chang EJ; Drapkin BJ; Cross FR; Chait BT; Rout MP
    Mol Cell; 2004 Jun; 14(6):699-711. PubMed ID: 15200949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new linear cyclin docking motif that mediates exclusively S-phase CDK-specific signaling.
    Faustova I; Bulatovic L; Matiyevskaya F; Valk E; Örd M; Loog M
    EMBO J; 2021 Jan; 40(2):e105839. PubMed ID: 33210757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-specific docking motifs promote phosphorylation of yeast signaling proteins by G1/S Cdk complexes.
    Bhaduri S; Pryciak PM
    Curr Biol; 2011 Oct; 21(19):1615-23. PubMed ID: 21945277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The yeast Pho80-Pho85 cyclin-CDK complex has multiple substrates.
    Waters NC; Knight JP; Creasy CL; Bergman LW
    Curr Genet; 2004 Jul; 46(1):1-9. PubMed ID: 15057567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase.
    Verma R; Annan RS; Huddleston MJ; Carr SA; Reynard G; Deshaies RJ
    Science; 1997 Oct; 278(5337):455-60. PubMed ID: 9334303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
    Bitter GA
    Mol Gen Genet; 1998 Oct; 260(1):120-30. PubMed ID: 9829836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophosphorylation-induced degradation of the Pho85 cyclin Pcl5 is essential for response to amino acid limitation.
    Aviram S; Simon E; Gildor T; Glaser F; Kornitzer D
    Mol Cell Biol; 2008 Nov; 28(22):6858-69. PubMed ID: 18794371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PCL2 (ORFD)-PHO85 cyclin-dependent kinase complex: a cell cycle regulator in yeast.
    Measday V; Moore L; Ogas J; Tyers M; Andrews B
    Science; 1994 Nov; 266(5189):1391-5. PubMed ID: 7973731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for identifying phosphorylated substrates of specific cyclin/cyclin-dependent kinase complexes.
    Li Y; Cross FR; Chait BT
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11323-8. PubMed ID: 25049391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential susceptibility of yeast S and M phase CDK complexes to inhibitory tyrosine phosphorylation.
    Keaton MA; Bardes ES; Marquitz AR; Freel CD; Zyla TR; Rudolph J; Lew DJ
    Curr Biol; 2007 Jul; 17(14):1181-9. PubMed ID: 17614281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of sic1, a cyclin-dependent kinase (Cdk) inhibitor, by Cdk including Pho85 kinase is required for its prompt degradation.
    Nishizawa M; Kawasumi M; Fujino M; Toh-e A
    Mol Biol Cell; 1998 Sep; 9(9):2393-405. PubMed ID: 9725902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation.
    Liu E; Li X; Yan F; Zhao Q; Wu X
    J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
    Zhu L; Harlow E; Dynlacht BD
    Genes Dev; 1995 Jul; 9(14):1740-52. PubMed ID: 7622038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Pcl7-Pho85 cyclin-cdk complex by Pho81.
    Lee M; O'Regan S; Moreau JL; Johnson AL; Johnston LH; Goding CR
    Mol Microbiol; 2000 Oct; 38(2):411-22. PubMed ID: 11069666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-Specific Docking Mechanisms Reveal the Complexity of M-CDK Function in the Cell Cycle.
    Örd M; Venta R; Möll K; Valk E; Loog M
    Mol Cell; 2019 Jul; 75(1):76-89.e3. PubMed ID: 31101497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchy of S-phase-promoting factors: yeast Dbf4-Cdc7 kinase requires prior S-phase cyclin-dependent kinase activation.
    Nougarède R; Della Seta F; Zarzov P; Schwob E
    Mol Cell Biol; 2000 Jun; 20(11):3795-806. PubMed ID: 10805723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of G1 Cyclin Docking Motif Sequences that Control CDK Regulatory Potency In Vivo.
    Bandyopadhyay S; Bhaduri S; Örd M; Davey NE; Loog M; Pryciak PM
    Curr Biol; 2020 Nov; 30(22):4454-4466.e5. PubMed ID: 32976810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.